Volatile Anesthetic Protection Of Renal Transplants 2

PHASE4CompletedINTERVENTIONAL
Enrollment

488

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

January 30, 2025

Study Completion Date

January 31, 2025

Conditions
Delayed Graft FunctionRenal Outcome After Kidney TransplantationAcute Rejection (AR) of Transplanted KidneyGraft SurvivalPatient SurvivalPostoperative ComplicationsLength of Hospital StayPrimary Non Function
Interventions
DRUG

sevoflurane

General anesthesia with sevoflurane

DRUG

propofol

General anesthesia with propofol

Trial Locations (5)

Unknown

Aarhus University Hospital, Aarhus

Amsterdam University Medical Center, Amsterdam

university Hospital Oslo, Oslo

Fundagio Puigvert, Barcelona

9728XR

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT02727296 - Volatile Anesthetic Protection Of Renal Transplants 2 | Biotech Hunter | Biotech Hunter